Form 8-K - Current report:
SEC Accession No. 0001641172-25-004958
Filing Date
2025-04-16
Accepted
2025-04-16 06:12:21
Documents
13
Period of Report
2025-04-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 26897
  Complete submission text file 0001641172-25-004958.txt   197671

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ladx-20250414.xsd EX-101.SCH 3017
3 XBRL LABEL FILE ladx-20250414_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE ladx-20250414_pre.xml EX-101.PRE 22360
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3645
Mailing Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049
Business Address 11726 SAN VICENTE BOULEVARD SUITE 650 LOS ANGELES CA 90049 310-826-5648
LadRx Corp (Filer) CIK: 0000799698 (see all company filings)

EIN.: 581642750 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15327 | Film No.: 25841162
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)